Alpha-GPC
A multicenter RCT in mild-to-moderate Alzheimer's dementia (De Jesus Moreno, 2003, n=261) found 1200mg/day improved ADAS-Cog, MMSE and global scores versus placebo at 90 and 180 days, and a 2023 meta-analysis supports benefit in cerebrovascular cognitive impairment. In healthy men, a single 315–630mg dose improved Stroop performance but not N-Back or Flanker (Kerksick 2024). Sports trials are inconsistent: a lower-body force gain after 6 days at 600mg (Bellar 2015), no strength effect at 250–500mg for 7 days, and no power-output effect after a single 630mg dose.
Evidence reviewed:
Mechanism of action
Alpha-GPC (alpha-glycerylphosphorylcholine) is the most bioavailable choline precursor. It delivers choline directly across the blood-brain barrier, where it is used to synthesise acetylcholine. It also supports cell membrane phospholipid synthesis. It is often marketed for growth hormone release, but a 2024 RCT at 630mg found no growth hormone difference versus placebo.
Clinical evidence summary
A multicenter RCT in mild-to-moderate Alzheimer's dementia (De Jesus Moreno, 2003, n=261) found 1200mg/day improved ADAS-Cog, MMSE and global scores versus placebo at 90 and 180 days, and a 2023 meta-analysis supports benefit in cerebrovascular cognitive impairment. In healthy men, a single 315–630mg dose improved Stroop performance but not N-Back or Flanker (Kerksick 2024). Sports trials are inconsistent: a lower-body force gain after 6 days at 600mg (Bellar 2015), no strength effect at 250–500mg for 7 days, and no power-output effect after a single 630mg dose.
Human effect matrix
Based on human clinical trials only. Animal and in-vitro data excluded.
| Effect | Evidence | Magnitude | Studies |
|---|---|---|---|
| Acetylcholine Synthesis | strong | Large | 2 |
| Memory & Cognition | moderate | Moderate | 2 |
| Athletic Power Output | mixed | Small | 3 |
| Neuroprotection | moderate | Moderate | 2 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Documented benefits
- Cognition in Alzheimer's and cerebrovascular dementia (1200mg/day)
- Acute Stroop (executive) performance in healthy men
- Raises plasma choline
Side effects & cautions
- Well tolerated
- Headache if combined with other cholinergics
- 500mg/day significantly suppressed serum TSH (thyroid-stimulating hormone) in a 7-day trial
How to take
Stacking recommendations
Ingredients that pair well with Alpha-GPC and why.
Alpha-GPC provides immediate acetylcholine support; Lion's Mane drives long-term NGF synthesis. Neither overlaps mechanistically — a clean acute + long-term pairing.
Alpha-GPC handles acute memory encoding via acetylcholine; Bacopa handles memory consolidation and storage. Together they cover both encoding and consolidation stages of memory formation.
Huperzine A prevents acetylcholine breakdown while Alpha-GPC increases acetylcholine synthesis. Powerful combination in theory — but use with caution and low doses, as cholinergic overload (nausea, headache, muscle cramps) is a real risk. Not recommended without experience.
Frequently asked questions
Alpha-GPC vs Citicoline — which is better for focus?
Both are excellent. Alpha-GPC has a slight edge for acute cholinergic effects and is preferred for workout performance. Citicoline also provides cytidine (uridine precursor), giving it a broader neuroprotective profile. For pure focus and acetylcholine, Alpha-GPC wins slightly; for comprehensive brain health support, Citicoline is more complete. Don't stack them together — you'll get too much choline activity.
Is it safe to combine Alpha-GPC with Huperzine A?
Use caution. Both increase acetylcholine (Alpha-GPC via synthesis, Huperzine A via inhibiting breakdown). The combination is potent and can cause cholinergic overstimulation — symptoms include nausea, headache, excessive salivation, and muscle cramps. If combining, use lower doses of each (e.g. 200mg Alpha-GPC + 50mcg Huperzine A) and do not take daily.
Why does Alpha-GPC powder go sticky?
Alpha-GPC is highly hygroscopic — it absorbs water from the air quickly. This is normal and doesn't affect potency. Store in an airtight container in a cool, dry place. Capsule form avoids this problem entirely.
Is there a cardiovascular risk with Alpha-GPC?
Unresolved. The CARDIA cohort study (published 2024) linked higher plasma choline — not alpha-GPC supplements — with incident cardiovascular disease, while a meta-analysis of dietary choline intake found no association. No study has tested alpha-GPC supplementation directly for cardiovascular outcomes. If you have cardiovascular disease, discuss it with your doctor.
Top stacks containing Alpha-GPC
Alpha-GPC in the Gulf
Alpha-GPC is not named in either the SFDA's Products Classification Guidance or Dubai Municipality's Technical Guidelines for Health Supplements. The closer reference point is choline itself: Dubai's Annex 1 sets an adult upper limit for "Choline" within its vitamins table, but Alpha-GPC (alpha-glycerylphosphorylcholine) is a distinct compound that the document does not mention by name, so this limit cannot be read as applying to it directly. Saudi Arabia's guidance places named ingredient categories among a food supplement's permitted components without addressing choline-donor compounds specifically. Neither document cited below classifies Alpha-GPC as permitted, restricted or banned.
Choline's upper limit vs. Alpha-GPC
Dubai Municipality's Annex 1 table lists Choline among vitamins with defined per-life-stage upper limits, giving adults a figure of 3,500 mg/day in the source's own table row: "Men 500 mg\day 2500mcg 3,500 mg/day Women 500 mg\day 2500mcg 3,500 mg/day" (the Pantothenic acid, Biotin and Choline columns). This limit is written against "Choline," the parent nutrient, not against "Alpha-GPC," "alpha-glycerylphosphorylcholine," or "GPC" — none of which appear anywhere in the document. Readers should not assume the Choline figure has been formally applied to Alpha-GPC by either GCC authority reviewed here.
Products in the Gulf
SFDA / Dubai Municipality
Is there an official upper limit for Alpha-GPC in the UAE or Saudi Arabia?
Not by that name. Dubai Municipality's Annex 1 sets an adult upper limit of 3,500 mg/day for "Choline" as a vitamin-category nutrient, but Alpha-GPC itself is never named in the document, so no source confirms this figure was written with Alpha-GPC in mind.
GCC country guides
Sources: Dubai Municipality — Technical Guidelines for Health Supplements (DM-HSD-GU29-TGHS2, V2.0, 4 May 2024) · Dubai Municipality — Technical Guidelines for Health Supplements (DM-HSD-GU29-TGHS2, V2.0, 4 May 2024) · SFDA — Products Classification Guidance (Version, published Dec 2024)
Regulatory note
Dietary supplements sold in Saudi Arabia are regulated by the Saudi Food and Drug Authority (SFDA); in the UAE, general food supplements are regulated by Dubai Municipality while products making medicinal or therapeutic claims require marketing authorisation from the Emirates Drug Establishment (EDE, ede.gov.ae), which now handles drug registrations previously processed through the Ministry of Health and Prevention (MOHAP). GCC consumers preference Halal-certified supplements; capsule shells (gelatin vs HPMC vegetable cellulose) are a meaningful differentiator. We surface Halal-certifying authority where verifiable and never fabricate certifications. This page is editorial, not medical advice. Always consult a qualified healthcare professional before starting any supplement.
Sources (7)expand
- PMID 36683513Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis (2023)
- PMID 12637119Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate (De Jesus Moreno, 2003) (2003)
- PMID 39683633Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men (2024)
- PMID 26582972The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength (Bellar et al., 2015) (2015)
- PMID 29042830Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance (2017)
- PMID 1428296A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers (1992)
- PMID 37865185Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study. (2024)